학술논문
Efficacy and Safety of Trastuzumab Deruxtecan and Nivolumab as Third-or Later-Line Treatment for HER2-Positive Advanced Gastric Cancer: A Single-Institution Retrospective Study
Document Type
Article
Author
Source
In: Journal of Gastric Cancer . (Journal of Gastric Cancer, Oct 2023, 23(4):609-621)
Subject
Language
English
ISSN
20935641
2093582X
2093582X